Injectables FDA approves Sanofi and Regeneron’s Dupixent for atopic dermatitis By Esthetic Advisor - September 13, 2022 0 141 Facebook Twitter Pinterest WhatsApp FDA approves Sanofi and Regeneron’s Dupixent for atopic dermatitis Pharmaceutical Business review is using cookies Close Source link